Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiantianma capsule plus amlodipine for essential hypertension
ChiCTR2300074597Phase 4Recruiting
- Sponsor
- Guang'anmen Hospital
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of xiantianma and amlodipine in essential hypertension (2 arms), sponsored by Guang'anmen Hospital. Primary endpoint: Clinic systolic blood pressure. Started Jul 2023; status: recruiting.
02
Drugs
xiantianmaamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR2300074597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074597.